120 related articles for article (PubMed ID: 11339917)
1. Psammoma bodies in cervicovaginal smears.
Zreik TG; Rutherford TJ
Obstet Gynecol; 2001 May; 97(5 Pt 1):693-5. PubMed ID: 11339917
[TBL] [Abstract][Full Text] [Related]
2. The significance of psammoma bodies in screening cervical cytologic smears.
Muntz HG; Goff BA; McGonigle K; Isacson C
Am J Obstet Gynecol; 2003 Jun; 188(6):1609-12; discussion 1612-4. PubMed ID: 12825000
[TBL] [Abstract][Full Text] [Related]
3. Psammoma bodies in cervicovaginal smears: incidence and significance.
Parkash V; Chacho MS
Diagn Cytopathol; 2002 Feb; 26(2):81-6. PubMed ID: 11813323
[TBL] [Abstract][Full Text] [Related]
4. Psammoma bodies in cervicovaginal smears: significance and practical implications for diagnostic cytopathology.
Fadare O; Chacho MS; Parkash V
Adv Anat Pathol; 2004 Sep; 11(5):250-61. PubMed ID: 15322491
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of psammoma bodies in Papanicolaou-stained cervicovaginal smears.
Kern SB
Acta Cytol; 1991; 35(1):81-8. PubMed ID: 1994642
[TBL] [Abstract][Full Text] [Related]
6. Psammoma bodies in cervical smears: sifting the grains of sand.
Smith JH
Cytopathology; 2007 Jun; 18(3):140-2. PubMed ID: 17573763
[No Abstract] [Full Text] [Related]
7. Psammoma bodies in cervicovaginal cytology specimens: a clinicopathological analysis of 31 cases.
Misdraji J; Vaidya A; Tambouret RH; Duska L; Bell DA
Gynecol Oncol; 2006 Oct; 103(1):238-46. PubMed ID: 16624389
[TBL] [Abstract][Full Text] [Related]
8. Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases.
Ersoy E; Kashikar RM
J Am Soc Cytopathol; 2020; 9(4):266-271. PubMed ID: 32376242
[TBL] [Abstract][Full Text] [Related]
9. Cervicovaginal psammoma bodies in endosalpingiosis. A case report.
Seguin RE; Ingram K
J Reprod Med; 2000 Jun; 45(6):526-8. PubMed ID: 10900592
[TBL] [Abstract][Full Text] [Related]
10. The significance of psammoma bodies on cervical cytology smears.
Nicklin JL; Perrin L; Obermair A; McConachie I; Cominos D
Gynecol Oncol; 2001 Oct; 83(1):6-9. PubMed ID: 11585407
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammocarcinoma.
Pusiol T; Parolari AM; Piscioli I; Morelli L; Del Nonno F; Licci S
Cytojournal; 2008 Apr; 5():7. PubMed ID: 18416848
[TBL] [Abstract][Full Text] [Related]
12. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy.
Mount SL; Wegner EK; Eltabbakh GH; Olmstead JI; Drejet AE
Obstet Gynecol; 2002 Sep; 100(3):445-50. PubMed ID: 12220762
[TBL] [Abstract][Full Text] [Related]
13. Ovarian carcinoma identified by psammoma bodies in the cervicovaginal and endometrial smears.
Qizilbash AH
Can Med Assoc J; 1974 Jan; 110(2):185-6. PubMed ID: 4810189
[TBL] [Abstract][Full Text] [Related]
14. Psammoma bodies found in cervicovaginal and/or endometrial smears.
Fujimoto I; Masubuchi S; Miwa H; Fukuda K; Yamaguchi S; Masubuchi K
Acta Cytol; 1982; 26(3):317-22. PubMed ID: 6954813
[TBL] [Abstract][Full Text] [Related]
15. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women.
Keating JT; Wang HH
Cancer; 2001 Apr; 93(2):100-5. PubMed ID: 11309774
[TBL] [Abstract][Full Text] [Related]
16. Endosalpingiosis as a source of psammoma bodies in a Papanicolaou smear. A case report.
Hallman KB; Nahhas WA; Connelly PJ
J Reprod Med; 1991 Sep; 36(9):675-8. PubMed ID: 1774734
[TBL] [Abstract][Full Text] [Related]
17. Cervicovaginal psammoma bodies. The initial presentation of the ovarian borderline tumor.
Qazi FM; Geisinger KR; Barrett RJ; Hopkins MB; Holleman IL
Arch Pathol Lab Med; 1988 May; 112(5):564-6. PubMed ID: 3358659
[TBL] [Abstract][Full Text] [Related]
18. Screening and early diagnosis of gynecologic cancers.
Warner EA; Parsons AK
Med Clin North Am; 1996 Jan; 80(1):45-61. PubMed ID: 8569300
[TBL] [Abstract][Full Text] [Related]
19. Determining the significance of psammoma bodies in pelvic washings: A 10-year retrospective review.
Sun T; Pitman MB; Torous VF
Cancer Cytopathol; 2021 Jan; 129(1):83-89. PubMed ID: 32931128
[TBL] [Abstract][Full Text] [Related]
20. Psammoma bodies and cells from in situ fallopian tube carcinoma in endometrial smears: a case report.
Luzzatto R; Sisson G; Luzzatto L; Recktenvald M; Brucker N
Acta Cytol; 1996; 40(2):295-8. PubMed ID: 8629414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
